Annual CFI
$4.21 B
+$9.38 B+181.26%
31 December 2023
Summary:
Moderna annual cash flow from investing activities is currently $4.21 billion, with the most recent change of +$9.38 billion (+181.26%) on 31 December 2023. During the last 3 years, it has risen by +$5.88 billion (+351.56%). MRNA annual CFI is now at all-time high.MRNA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$721.00 M
-$928.00 M-56.28%
30 September 2024
Summary:
Moderna quarterly cash flow from investing activities is currently $721.00 million, with the most recent change of -$928.00 million (-56.28%) on 30 September 2024. Over the past year, it has dropped by -$68.00 million (-8.62%). MRNA quarterly CFI is now -64.15% below its all-time high of $2.01 billion, reached on 31 March 2023.MRNA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$1.95 B
-$68.00 M-3.37%
30 September 2024
Summary:
Moderna TTM cash flow from investing activities is currently $1.95 billion, with the most recent change of -$68.00 million (-3.37%) on 30 September 2024. Over the past year, it has dropped by -$1.75 billion (-47.24%). MRNA TTM CFI is now -53.64% below its all-time high of $4.21 billion, reached on 31 December 2023.MRNA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +181.3% | -8.6% | -47.2% |
| 3 y3 years | +351.6% | +121.7% | +125.7% |
| 5 y5 years | +1227.3% | +536.0% | +1501.7% |
MRNA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +149.3% | -64.2% | +118.4% | -53.6% | +115.9% |
| 5 y | 5 years | at high | +149.3% | -64.2% | +118.4% | -53.6% | +115.9% |
| alltime | all time | at high | +149.3% | -64.2% | +118.4% | -53.6% | +115.9% |
Moderna Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $721.00 M(-56.3%) | $1.95 B(-3.4%) |
| June 2024 | - | $1.65 B(+1297.5%) | $2.02 B(-12.8%) |
| Mar 2024 | - | $118.00 M(-121.9%) | $2.31 B(-45.0%) |
| Dec 2023 | $4.21 B(-181.3%) | -$538.00 M(-168.2%) | $4.21 B(+13.8%) |
| Sept 2023 | - | $789.00 M(-59.4%) | $3.70 B(-4.0%) |
| June 2023 | - | $1.94 B(-3.3%) | $3.85 B(+409.5%) |
| Mar 2023 | - | $2.01 B(-291.9%) | $756.00 M(-114.6%) |
| Dec 2022 | -$5.18 B(-39.3%) | -$1.05 B(-210.9%) | -$5.18 B(-1.7%) |
| Sept 2022 | - | $945.00 M(-182.0%) | -$5.27 B(-44.8%) |
| June 2022 | - | -$1.15 B(-70.6%) | -$9.54 B(-22.2%) |
| Mar 2022 | - | -$3.92 B(+244.6%) | -$12.26 B(+43.9%) |
| Dec 2021 | -$8.52 B(+409.7%) | -$1.14 B(-65.8%) | -$8.52 B(+12.5%) |
| Sept 2021 | - | -$3.33 B(-14.2%) | -$7.58 B(+39.6%) |
| June 2021 | - | -$3.88 B(+2054.4%) | -$5.43 B(+253.3%) |
| Mar 2021 | - | -$180.00 M(-5.3%) | -$1.54 B(-8.1%) |
| Dec 2020 | -$1.67 B(>+9900.0%) | -$190.00 M(-83.9%) | -$1.67 B(+23.7%) |
| Sept 2020 | - | -$1.18 B(-9169.2%) | -$1.35 B(+2177.9%) |
| June 2020 | - | $13.00 M(-104.1%) | -$59.34 M(-81.4%) |
| Mar 2020 | - | -$316.00 M(-342.5%) | -$319.24 M(+2028.3%) |
| Dec 2019 | -$15.00 M(-96.0%) | $130.29 M(+14.9%) | -$15.00 M(-89.2%) |
| Sept 2019 | - | $113.37 M(-145.9%) | -$139.12 M(+2.0%) |
| June 2019 | - | -$246.90 M(+1999.7%) | -$136.41 M(-238.0%) |
| Mar 2019 | - | -$11.76 M(-290.5%) | $98.85 M(-126.5%) |
| Dec 2018 | -$373.09 M(-189.4%) | $6.17 M(-94.7%) | -$373.09 M(-1.6%) |
| Sept 2018 | - | $116.08 M(-1096.8%) | -$379.27 M(-23.4%) |
| June 2018 | - | -$11.64 M(-97.6%) | -$495.42 M(+2.3%) |
| Mar 2018 | - | -$483.70 M(<-9900.0%) | -$484.08 M(>+9900.0%) |
| Dec 2017 | $417.36 M(-164.3%) | $0.00(-100.0%) | -$375.00 K(+1.6%) |
| Sept 2017 | - | -$75.00 K(-75.0%) | -$369.10 K(+25.5%) |
| June 2017 | - | -$300.00 K(-5184.7%) | -$294.10 K(-5084.7%) |
| Dec 2016 | -$648.61 M(>+9900.0%) | - | - |
| Dec 2016 | - | $5900.00(>+9900.0%) | $5900.00(>+9900.0%) |
| Sept 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2015 | -$45.00 K(<-9900.0%) | - | - |
| Dec 2014 | $0.00(-100.0%) | - | - |
| Dec 2013 | $410.00 K(-61.4%) | $0.00(0.0%) | $410.00 K(-47.6%) |
| Sept 2013 | - | $0.00(-100.0%) | $782.00 K(-42.2%) |
| June 2013 | - | $30.00 K(-92.1%) | $1.35 M(-4.5%) |
| Mar 2013 | - | $380.00 K(+2.2%) | $1.42 M(+33.3%) |
| Dec 2012 | $1.06 M(>+9900.0%) | $372.00 K(-34.7%) | $1.06 M(+27.5%) |
| Sept 2012 | - | $570.00 K(+506.4%) | $833.00 K(+216.7%) |
| June 2012 | - | $94.00 K(+261.5%) | $263.00 K(+55.6%) |
| Mar 2012 | - | $26.00 K(-81.8%) | $169.00 K(+5533.3%) |
| Dec 2011 | $3000.00(-99.9%) | $143.00 K(>+9900.0%) | $3000.00(-113.0%) |
| Sept 2011 | - | $0.00(0.0%) | -$23.00 K(-100.5%) |
| June 2011 | - | $0.00(-100.0%) | $4.82 M(+0.7%) |
| Mar 2011 | - | -$140.00 K(-219.7%) | $4.78 M(+3.1%) |
| Dec 2010 | $4.64 M(+98.7%) | $117.00 K(-97.6%) | $4.64 M(-0.8%) |
| Sept 2010 | - | $4.84 M(<-9900.0%) | $4.68 M(+8728.3%) |
| June 2010 | - | -$33.00 K(-88.4%) | $53.00 K(-95.0%) |
| Mar 2010 | - | -$284.00 K(-282.1%) | $1.06 M(-54.6%) |
| Dec 2009 | $2.33 M(-80.7%) | $156.00 K(-27.1%) | $2.33 M(+12.0%) |
| Sept 2009 | - | $214.00 K(-78.0%) | $2.08 M(-37.9%) |
| June 2009 | - | $974.00 K(-1.7%) | $3.35 M(-56.1%) |
| Mar 2009 | - | $991.00 K(-1143.2%) | $7.65 M(-36.8%) |
| Dec 2008 | $12.10 M | -$95.00 K(-106.4%) | $12.10 M(-17.6%) |
| Sept 2008 | - | $1.48 M(-71.8%) | $14.69 M(+12.9%) |
| June 2008 | - | $5.27 M(-3.3%) | $13.01 M(-37.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $5.45 M(+118.7%) | $20.72 M(+343.1%) |
| Dec 2007 | $4.67 M(+806.0%) | $2.49 M(-1370.4%) | $4.67 M(-60.6%) |
| Sept 2007 | - | -$196.00 K(-101.5%) | $11.87 M(+6.0%) |
| June 2007 | - | $12.98 M(-222.5%) | $11.20 M(-1754.5%) |
| Mar 2007 | - | -$10.60 M(-209.4%) | -$677.00 K(-231.2%) |
| Dec 2006 | $516.00 K(-79.0%) | $9.69 M(-1217.3%) | $516.00 K(-93.6%) |
| Sept 2006 | - | -$867.00 K(-178.9%) | $8.08 M(-364.1%) |
| June 2006 | - | $1.10 M(-111.7%) | -$3.06 M(-50.2%) |
| Mar 2006 | - | -$9.40 M(-154.5%) | -$6.14 M(-349.5%) |
| Dec 2005 | $2.46 M(-107.3%) | $17.25 M(-243.7%) | $2.46 M(-105.0%) |
| Sept 2005 | - | -$12.01 M(+504.7%) | -$49.18 M(+44.7%) |
| June 2005 | - | -$1.99 M(+149.8%) | -$33.98 M(-0.1%) |
| Mar 2005 | - | -$795.00 K(-97.7%) | -$34.00 M(+1.3%) |
| Dec 2004 | -$33.55 M(-1063.6%) | -$34.39 M(-1176.4%) | -$33.55 M(<-9900.0%) |
| Sept 2004 | - | $3.19 M(-258.8%) | $145.00 K(-126.2%) |
| June 2004 | - | -$2.01 M(+483.2%) | -$553.00 K(-114.2%) |
| Mar 2004 | - | -$345.00 K(-50.2%) | $3.89 M(+11.8%) |
| Dec 2003 | $3.48 M(-191.2%) | -$693.00 K(-127.8%) | $3.48 M(+2.5%) |
| Sept 2003 | - | $2.50 M(+2.6%) | $3.40 M(-375.1%) |
| June 2003 | - | $2.43 M(-422.3%) | -$1.24 M(-72.1%) |
| Mar 2003 | - | -$755.00 K(-3.0%) | -$4.43 M(+15.9%) |
| Dec 2002 | -$3.82 M(+2571.3%) | -$778.00 K(-63.6%) | -$3.82 M(+24.6%) |
| Sept 2002 | - | -$2.13 M(+180.6%) | -$3.06 M(+211.2%) |
| June 2002 | - | -$761.00 K(+421.2%) | -$985.00 K(+313.9%) |
| Mar 2002 | - | -$146.00 K(+534.8%) | -$238.00 K(+66.4%) |
| Dec 2001 | -$143.00 K(-104.2%) | -$23.00 K(-58.2%) | -$143.00 K(-17.8%) |
| Sept 2001 | - | -$55.00 K(+292.9%) | -$174.00 K(+10.8%) |
| June 2001 | - | -$14.00 K(-72.5%) | -$157.00 K(-40.1%) |
| Mar 2001 | - | -$51.00 K(-5.6%) | -$262.00 K(-107.7%) |
| Dec 2000 | $3.42 M(-148.9%) | -$54.00 K(+42.1%) | $3.42 M(-298.5%) |
| Sept 2000 | - | -$38.00 K(-68.1%) | -$1.72 M(-38.1%) |
| June 2000 | - | -$119.00 K(-103.3%) | -$2.79 M(-9.2%) |
| Mar 2000 | - | $3.63 M(-169.9%) | -$3.07 M(-56.2%) |
| Dec 1999 | -$7.00 M(+1066.7%) | -$5.20 M(+372.7%) | -$7.00 M(+268.4%) |
| Sept 1999 | - | -$1.10 M(+175.0%) | -$1.90 M(+90.0%) |
| June 1999 | - | -$400.00 K(+33.3%) | -$1.00 M(-145.5%) |
| Mar 1999 | - | -$300.00 K(+200.0%) | $2.20 M(-466.7%) |
| Dec 1998 | -$600.00 K(-109.4%) | -$100.00 K(-50.0%) | -$600.00 K(0.0%) |
| Sept 1998 | - | -$200.00 K(-107.1%) | -$600.00 K(-140.0%) |
| June 1998 | - | $2.80 M(-190.3%) | $1.50 M(-11.8%) |
| Mar 1998 | - | -$3.10 M(+3000.0%) | $1.70 M(-73.4%) |
| Dec 1997 | $6.40 M(-288.2%) | -$100.00 K(-105.3%) | $6.40 M(-1.5%) |
| Sept 1997 | - | $1.90 M(-36.7%) | $6.50 M(+160.0%) |
| June 1997 | - | $3.00 M(+87.5%) | $2.50 M(-1350.0%) |
| Mar 1997 | - | $1.60 M(-176.2%) | -$200.00 K(-88.9%) |
| Dec 1996 | -$3.40 M(-1800.0%) | - | - |
| Sept 1996 | - | -$2.10 M(-800.0%) | -$1.80 M(-1000.0%) |
| June 1996 | $200.00 K(0.0%) | $300.00 K(-250.0%) | $200.00 K(-85.7%) |
| Mar 1996 | - | -$200.00 K(-200.0%) | $1.40 M(-12.5%) |
| Dec 1995 | - | $200.00 K(-300.0%) | $1.60 M(-366.7%) |
| Sept 1995 | - | -$100.00 K(-106.7%) | -$600.00 K(-400.0%) |
| June 1995 | $200.00 K(-110.0%) | $1.50 M(>+9900.0%) | $200.00 K(-115.4%) |
| Mar 1995 | - | $0.00(-100.0%) | -$1.30 M(0.0%) |
| Dec 1994 | - | -$2.00 M(-385.7%) | -$1.30 M(+8.3%) |
| Sept 1994 | - | $700.00 K(>+9900.0%) | -$1.20 M(-40.0%) |
| June 1994 | -$2.00 M | $0.00(0.0%) | -$2.00 M(0.0%) |
| Mar 1994 | - | $0.00(-100.0%) | -$2.00 M(0.0%) |
| Dec 1993 | - | -$1.90 M(+1800.0%) | -$2.00 M(+1900.0%) |
| Sept 1993 | - | -$100.00 K | -$100.00 K |
FAQ
- What is Moderna annual cash flow from investing activities?
- What is the all time high annual CFI for Moderna?
- What is Moderna annual CFI year-on-year change?
- What is Moderna quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Moderna?
- What is Moderna quarterly CFI year-on-year change?
- What is Moderna TTM cash flow from investing activities?
- What is the all time high TTM CFI for Moderna?
- What is Moderna TTM CFI year-on-year change?
What is Moderna annual cash flow from investing activities?
The current annual CFI of MRNA is $4.21 B
What is the all time high annual CFI for Moderna?
Moderna all-time high annual cash flow from investing activities is $4.21 B
What is Moderna annual CFI year-on-year change?
Over the past year, MRNA annual cash flow from investing activities has changed by +$9.38 B (+181.26%)
What is Moderna quarterly cash flow from investing activities?
The current quarterly CFI of MRNA is $721.00 M
What is the all time high quarterly CFI for Moderna?
Moderna all-time high quarterly cash flow from investing activities is $2.01 B
What is Moderna quarterly CFI year-on-year change?
Over the past year, MRNA quarterly cash flow from investing activities has changed by -$68.00 M (-8.62%)
What is Moderna TTM cash flow from investing activities?
The current TTM CFI of MRNA is $1.95 B
What is the all time high TTM CFI for Moderna?
Moderna all-time high TTM cash flow from investing activities is $4.21 B
What is Moderna TTM CFI year-on-year change?
Over the past year, MRNA TTM cash flow from investing activities has changed by -$1.75 B (-47.24%)